Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aspirin/lansoprazole - Takeda

Next Previous
X
Search
Drug Profile

Aspirin/lansoprazole - Takeda

Alternative Names: Aspirin/AG-1749; Lansoprazole/aspirin; Takelda; Takepron/low-dose aspirin

Latest Information Update: 30 Jan 2019

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Takeda
  • Class Antiplatelets; Antipyretics; Antiulcers; Benzimidazoles; Gastric antisecretories; Nonsteroidal anti-inflammatories; Pyridines; Salicylic acids; Small molecules; Sulfoxides
  • Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide stimulants; Platelet aggregation inhibitors; Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cardiovascular disorders

Most Recent Events

  • 30 Jan 2019 Chemical structure information added
  • 13 Jun 2014 Launched for Cardiovascular disorders (secondary prevention in patients at risk for aspirin-associated gastric ulcers) in Japan (PO)
  • 24 Mar 2014 Registered for Duodenal ulcer (prevention) in Japan (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top